This interesting article raises once again the issue of whether or not allogeneic transfusion can hasten the relapse of cancer and shorten overall survival. There is a lot of information both ways, so the issue is not settled. The current paper suggests that allogeneic transfusion is doing something that autologous transfusion is not. It is […]
The Editorial by Bruce Spiess enthusiastically supports the work of Engoren et al. on the effects of blood transfusions on long-term survival after coronary artery bypass surgery while recognizing that databased research suffers several limitations. The author mentions that other databased studies, including ours, have examined outcomes and lowest hematocrit, found bad outcomes associated with […]
Note: It is difficult to ascertain transfusion as a factor entirely separate from co-morbidity. – F. Regan and M. Contreras.
Chagnon and colleagues provide with detailed description of treatment approaches to liver cancer. They focus on the use of radiofrequency ablation of lesions coupled with ultrasonographic imaging as a guide to success. Their excellent discussion of options, inclusion and exclusion criteria and outcomes is well worth reading. Every general surgeon must be aware of the […]